Edition:
United States

OncoMed Pharmaceuticals Inc (OMED.OQ)

OMED.OQ on NASDAQ Stock Exchange Global Select Market

2.91USD
4:00pm EDT
Change (% chg)

$0.25 (+9.18%)
Prev Close
$2.67
Open
$2.71
Day's High
$2.97
Day's Low
$2.66
Volume
27,877
Avg. Vol
60,431
52-wk High
$5.55
52-wk Low
$1.75

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 20.64 0.220
Sep '17 5.11 -0.284
Jun '17 6.20 -0.405
Mar '17 6.21 -0.607
FY 2016 Dec '16 6.22 -0.602
Sep '16 5.92 -0.766
Jun '16 6.66 -0.914
Mar '16 6.35 -0.900
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 5 6.32 8.98 5.00 12.54
Quarter Ending Sep-18 5 6.41 9.43 5.00 12.54
Year Ending Dec-18 5 25.56 37.10 20.00 52.66
Year Ending Dec-19 5 20.73 27.83 0.00 125.06
Earnings (per share)
Quarter Ending Jun-18 5 -0.22 -0.15 -0.36 -0.56
Quarter Ending Sep-18 5 -0.22 -0.13 -0.36 -0.56
Year Ending Dec-18 5 -0.87 -0.51 -1.41 -1.69
Year Ending Dec-19 5 -1.00 -0.49 -1.86 -0.03
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 178.44 32.31
P/E High - Last 5 Yrs. -- 280.78 46.12
P/E Low - Last 5 Yrs. -- 95.19 24.71
Beta 1.79 0.75 0.79
Price to Sales (TTM) 2.93 144.18 7.14
Price to Book (MRQ) -- 18.80 4.88
Price to Tangible Book (MRQ) -- 23.34 6.49
Price to Cash Flow (TTM) -- 117.05 24.37
% Owned Institutions 69.55 11.29 2.32

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.58
Dividend Yield - 5 Year Avg 0.00 0.20 0.78
Dividend 5 Year Growth Rate -- 1.96 4.08
Payout Ratio(TTM) -- 9.23 21.09

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 231.92 103.37 9.18
Sales (TTM) vs TTM 1 Yr. Ago 51.68 79.40 11.01
Sales - 5 Yr. Growth Rate 9.10 33.48 8.23
EPS (MRQ) vs Qtr. 1 Yr. Ago 136.62 -66.76 23.62
EPS (TTM) vs TTM 1 Yr. Ago 64.78 -- --
EPS - 5 Yr. Growth Rate -- 46.41 10.39
Capital Spending - 5 Yr. Growth Rate -3.91 44.90 10.47

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.70 2.52
Current Ratio (MRQ) 1.13 5.99 3.58
LT Debt to Equity (MRQ) -- 23.56 11.61
Total Debt to Equity (MRQ) -- 26.01 14.31
Interest Coverage (TTM) -- -183.16 30.88

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 31.78 54.20
Gross Margin - 5 Yr. Avg. -- 55.29 52.34
EBITD Margin (TTM) -96.29 -- --
EBITD - 5 Yr. Avg -176.53 -149.45 15.90
Operating Margin (TTM) -107.39 -587.01 3.62
Operating Margin - 5 Yr. Avg. -182.80 -161.52 11.17
Pre-Tax Margin (TTM) -105.22 -560.40 4.27
Pre-Tax Margin - 5 Yr. Avg. -182.09 -168.41 11.48
Net Profit Margin (TTM) -105.27 -548.74 0.90
Net Profit Margin - 5 Yr. Avg. -182.99 -168.67 7.81
Effective Tax Rate (TTM) -- -0.45 31.67
Effective Tax Rate - 5 Yr. Avg. -- 18.02 24.29

Efficiency

  Company industry sector
Revenue/Employee (TTM) 681,304 23,441,753 786,924,448
Net Income/Employee (TTM) -717,179 684,681 92,306,248
Receivable Turnover (TTM) 26.13 6.13 5.48
Inventory Turnover (TTM) -- 2.39 3.46
Asset Turnover (TTM) 0.25 0.40 0.87

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -26.27 -0.78 10.35
Return on Assets - 5 Yr. Avg. -27.46 0.53 11.38
Return on Investment (TTM) -51.22 -0.73 12.97
Return on Investment - 5 Yr. Avg. -36.10 3.99 14.74
Return on Equity (TTM) -- -2.77 14.84
Return on Equity - 5 Yr. Avg. -387.74 -0.21 16.08
  1 Year 3 Year 5 Year
Sales % 51.69 -1.20 9.10
EPS (TTM) % 65.99 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for OncoMed Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -17.85 -18.53 15 7
13 Week -8.56 -1.46 54 58
26 Week -31.89 -33.58 19 87
52 Week -29.18 -36.18 32 78
YTD -34.88 -33.91 15 87
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 69.55%
# of Holders: 90
Total Shares Held: 26,608,612
3 Mo. Net Change: 53,843
# New Positions: 2
# Closed Positions: 1
# Increased Positions: 2
# Reduced Positions: 2
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.